Year |
Citation |
Score |
2022 |
Onimus O, Valjent E, Fisone G, Gangarossa G. Haloperidol-Induced Immediate Early Genes in Striatopallidal Neurons Requires the Converging Action of cAMP/PKA/DARPP-32 and mTOR Pathways. International Journal of Molecular Sciences. 23. PMID 36232936 DOI: 10.3390/ijms231911637 |
0.373 |
|
2022 |
Korchynska S, Rebernik P, Pende M, Boi L, Alpár A, Tasan R, Becker K, Balueva K, Saghafi S, Wulff P, Horvath TL, Fisone G, Dodt HU, Hökfelt T, Harkany T, et al. A hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice. Nature Communications. 13: 5944. PMID 36209152 DOI: 10.1038/s41467-022-33584-3 |
0.325 |
|
2022 |
Smedler E, Louhivuori L, Romanov RA, Masini D, Dehnisch Ellström I, Wang C, Caramia M, West Z, Zhang S, Rebellato P, Malmersjö S, Brusini I, Kanatani S, Fisone G, Harkany T, et al. Disrupted gene expression perturbs spontaneous Ca activity causing abnormal brain development and increased anxiety. Proceedings of the National Academy of Sciences of the United States of America. 119. PMID 35135875 DOI: 10.1073/pnas.2108768119 |
0.746 |
|
2021 |
Masini D, Plewnia C, Bertho M, Scalbert N, Caggiano V, Fisone G. A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson's Disease for the Study of Non-Motor Symptoms. Biomedicines. 9. PMID 34070345 DOI: 10.3390/biomedicines9060598 |
0.789 |
|
2020 |
Zattoni M, Garrovo C, Xerxa E, Spigolon G, Fisone G, Kristensson K, Legname G. NMDA Receptor and L-Type Calcium Channel Modulate Prion Formation. Cellular and Molecular Neurobiology. PMID 32239389 DOI: 10.1007/S10571-020-00834-1 |
0.336 |
|
2020 |
Plewnia C, Masini D, Fisone G. P.327 Non-motor complications induced by dopamine replacement therapy in a mouse model of Parkinson's disease European Neuropsychopharmacology. 31: S67. DOI: 10.1016/J.Euroneuro.2019.12.090 |
0.784 |
|
2019 |
Medeiros DC, Lopes Aguiar C, Moraes MFD, Fisone G. Sleep Disorders in Rodent Models of Parkinson's Disease. Frontiers in Pharmacology. 10: 1414. PMID 31827439 DOI: 10.3389/Fphar.2019.01414 |
0.381 |
|
2019 |
Falconi A, Bonito-Oliva A, Di Bartolomeo M, Massimini M, Fattapposta F, Locuratolo N, Dainese E, Pascale E, Fisone G, D'Addario C. On the Role of Adenosine A2A Receptor Gene Transcriptional Regulation in Parkinson's Disease. Frontiers in Neuroscience. 13: 683. PMID 31354407 DOI: 10.3389/Fnins.2019.00683 |
0.386 |
|
2019 |
Adem A, Madjid N, Stiedl O, Bonito-Oliva A, Konradsson-Geuken Å, Holst S, Fisone G, Ögren SO. Atypical but not typical antipsychotic drugs ameliorate phencyclidine-induced emotional memory impairments in mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30910381 DOI: 10.1016/J.Euroneuro.2019.03.007 |
0.332 |
|
2018 |
Stagkourakis S, Spigolon G, Williams P, Protzmann J, Fisone G, Broberger C. A neural network for intermale aggression to establish social hierarchy. Nature Neuroscience. 21: 834-842. PMID 29802391 DOI: 10.1038/S41593-018-0153-X |
0.64 |
|
2018 |
Masini D, Bonito-Oliva A, Bertho M, Fisone G. Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson's Disease. Frontiers in Neurology. 9: 208. PMID 29686643 DOI: 10.3389/Fneur.2018.00208 |
0.788 |
|
2018 |
Spigolon G, Fisone G. Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29396608 DOI: 10.1007/S00702-018-1847-7 |
0.465 |
|
2018 |
Caggiano V, Leiras R, Goñi-Erro H, Masini D, Bellardita C, Bouvier J, Caldeira V, Fisone G, Kiehn O. Midbrain circuits that set locomotor speed and gait selection. Nature. PMID 29342142 DOI: 10.1038/Nature25448 |
0.757 |
|
2017 |
Spigolon G, Cavaccini A, Trusel M, Tonini R, Fisone G. cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease. Neurobiology of Disease. PMID 29107639 DOI: 10.1016/J.Nbd.2017.10.015 |
0.526 |
|
2017 |
Ketzef M, Spigolon G, Johansson Y, Bonito-Oliva A, Fisone G, Silberberg G. Dopamine Depletion Impairs Bilateral Sensory Processing in the Striatum in a Pathway-Dependent Manner. Neuron. 94: 855-865.e5. PMID 28521136 DOI: 10.1016/J.Neuron.2017.05.004 |
0.451 |
|
2017 |
di Val Cervo PR, Romanov RA, Spigolon G, Masini D, Martín-Montañez E, Toledo EM, La Manno G, Feyder M, Pifl C, Ng YH, Sánchez SP, Linnarsson S, Wernig M, Harkany T, Fisone G, et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nature Biotechnology. PMID 28398344 DOI: 10.1038/Nbt.3835 |
0.777 |
|
2017 |
Masini D, Lopes-Aguiar C, Bonito-Oliva A, Papadia D, Andersson R, Fisahn A, Fisone G. The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism. Translational Psychiatry. 7. PMID 28398338 DOI: 10.1038/Tp.2017.58 |
0.752 |
|
2016 |
Carta AR, Mulas G, Bortolanza M, Duarte T, Pillai E, Fisone G, Vozari Raisman R, Del Bel E. L-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role? The European Journal of Neuroscience. PMID 27859864 DOI: 10.1111/Ejn.13482 |
0.406 |
|
2016 |
Bonito-Oliva A, Södersten E, Spigolon G, Hu X, Hellysaz A, Falconi A, Gomes AL, Broberger C, Hansen K, Fisone G. Differential Regulation of the Phosphorylation of Trimethyl-lysine27 Histone H3 at Serine 28 in Distinct Populations of Striatal Projection Neurons. Neuropharmacology. PMID 26947946 DOI: 10.1016/J.Neuropharm.2016.02.037 |
0.676 |
|
2015 |
Bonito-Oliva A, DuPont C, Madjid N, Ögren SO, Fisone G. Involvement of the Striatal Medium Spiny Neurons of the Direct Pathway in the Motor Stimulant Effects of Phencyclidine. The International Journal of Neuropsychopharmacology. PMID 26657176 DOI: 10.1093/Ijnp/Pyv134 |
0.465 |
|
2015 |
Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/J.Pneurobio.2015.07.002 |
0.366 |
|
2014 |
Fuxe K, Borroto-Escuela D, Fisone G, Agnati LF, Tanganelli S. Understanding the role of heteroreceptor complexes in the central nervous system. Current Protein & Peptide Science. 15: 647. PMID 25256022 DOI: 10.2174/138920371507140916122738 |
0.358 |
|
2014 |
Södersten E, Feyder M, Lerdrup M, Gomes AL, Kryh H, Spigolon G, Caboche J, Fisone G, Hansen K. Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism. Plos Genetics. 10: e1004574. PMID 25254549 DOI: 10.1371/Journal.Pgen.1004574 |
0.445 |
|
2014 |
Bonito-Oliva A, Masini D, Fisone G. A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions. Frontiers in Behavioral Neuroscience. 8: 290. PMID 25221486 DOI: 10.3389/Fnbeh.2014.00290 |
0.796 |
|
2014 |
Feyder M, Södersten E, Santini E, Vialou V, LaPlant Q, Watts EL, Spigolon G, Hansen K, Caboche J, Nestler EJ, Fisone G. A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression. Biological Psychiatry. PMID 25193242 DOI: 10.1016/J.Biopsych.2014.07.019 |
0.388 |
|
2014 |
Mango D, Bonito-Oliva A, Ledonne A, Cappellacci L, Petrelli R, Nisticò R, Berretta N, Fisone G, Mercuri NB. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice. Experimental Neurology. 261: 733-43. PMID 25173217 DOI: 10.1016/J.Expneurol.2014.08.022 |
0.442 |
|
2014 |
Mango D, Bonito-Oliva A, Ledonne A, Nisticò R, Castelli V, Giorgi M, Sancesario G, Fisone G, Berretta N, Mercuri NB. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions. Neuropharmacology. 76: 127-36. PMID 23973317 DOI: 10.1016/J.Neuropharm.2013.08.010 |
0.452 |
|
2014 |
Bonito-Oliva A, Pignatelli M, Spigolon G, Yoshitake T, Seiler S, Longo F, Piccinin S, Kehr J, Mercuri NB, Nisticò R, Fisone G. Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism. Biological Psychiatry. 75: 701-10. PMID 23541633 DOI: 10.1016/J.Biopsych.2013.02.015 |
0.373 |
|
2013 |
Solari N, Bonito-Oliva A, Fisone G, Brambilla R. Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models. Learning & Memory (Cold Spring Harbor, N.Y.). 20: 592-600. PMID 24049188 DOI: 10.1101/Lm.032029.113 |
0.389 |
|
2013 |
Dupuis JP, Feyder M, Miguelez C, Garcia L, Morin S, Choquet D, Hosy E, Bezard E, Fisone G, Bioulac BH, Baufreton J. Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 14331-41. PMID 24005286 DOI: 10.1523/Jneurosci.1681-13.2013 |
0.472 |
|
2013 |
Allard EK, Grujic M, Fisone G, Kristensson K. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1. Neurobiology of Disease. 58: 116-22. PMID 23742760 DOI: 10.1016/J.Nbd.2013.05.014 |
0.369 |
|
2013 |
Bonito-Oliva A, Pallottino S, Bertran-Gonzalez J, Girault JA, Valjent E, Fisone G. Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1. Neuropharmacology. 72: 197-203. PMID 23643747 DOI: 10.1016/J.Neuropharm.2013.04.043 |
0.469 |
|
2013 |
Amalric M, Lopez S, Goudet C, Fisone G, Battaglia G, Nicoletti F, Pin JP, Acher FC. Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease. Neuropharmacology. 66: 53-64. PMID 22664304 DOI: 10.1016/J.Neuropharm.2012.05.026 |
0.434 |
|
2013 |
Dell'anno MT, Pallottino S, Fisone G. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons. Neuropharmacology. 66: 179-86. PMID 22507666 DOI: 10.1016/J.Neuropharm.2012.03.025 |
0.777 |
|
2012 |
Carta AR, Giuffrida A, Fisone G. Dyskinesia in Parkinson's disease therapy. Parkinson's Disease. 2012: 639080. PMID 23304638 DOI: 10.1155/2012/639080 |
0.382 |
|
2012 |
Fisone G, Brambilla R. Neuronal signaling and behavior. Frontiers in Behavioral Neuroscience. 6: 72. PMID 23129996 DOI: 10.3389/Fnbeh.2012.00072 |
0.414 |
|
2012 |
Santini E, Feyder M, Gangarossa G, Bateup HS, Greengard P, Fisone G. Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism. The Journal of Biological Chemistry. 287: 27806-12. PMID 22753408 DOI: 10.1074/Jbc.M112.388413 |
0.461 |
|
2011 |
Lopez S, Bonito-Oliva A, Pallottino S, Acher F, Fisone G. Activation of metabotropic glutamate 4 receptors decreases L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease. Journal of Parkinson's Disease. 1: 339-46. PMID 23939343 DOI: 10.3233/Jpd-2011-11066 |
0.412 |
|
2011 |
Feyder M, Bonito-Oliva A, Fisone G. L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. Frontiers in Behavioral Neuroscience. 5: 71. PMID 22028687 DOI: 10.3389/Fnbeh.2011.00071 |
0.511 |
|
2011 |
Errico F, Bonito-Oliva A, Bagetta V, Vitucci D, Romano R, Zianni E, Napolitano F, Marinucci S, Di Luca M, Calabresi P, Fisone G, Carta M, Picconi B, Gardoni F, Usiello A. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia. Experimental Neurology. 232: 240-50. PMID 21946266 DOI: 10.1016/J.Expneurol.2011.09.013 |
0.414 |
|
2011 |
Fisone G, Bezard E. Molecular mechanisms of l-DOPA-induced dyskinesia. International Review of Neurobiology. 98: 95-122. PMID 21907084 DOI: 10.1016/B978-0-12-381328-2.00004-3 |
0.411 |
|
2011 |
Valjent E, Bertran-Gonzalez J, Bowling H, Lopez S, Santini E, Matamales M, Bonito-Oliva A, Hervé D, Hoeffer C, Klann E, Girault JA, Fisone G. Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2561-70. PMID 21814187 DOI: 10.1038/Npp.2011.144 |
0.462 |
|
2011 |
Bonito-Oliva A, Feyder M, Fisone G. Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling. Frontiers in Neuroanatomy. 5: 38. PMID 21808606 DOI: 10.3389/Fnana.2011.00038 |
0.502 |
|
2011 |
Gangarossa G, Di Benedetto M, O'Sullivan GJ, Dunleavy M, Alcacer C, Bonito-Oliva A, Henshall DC, Waddington JL, Valjent E, Fisone G. Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus. Plos One. 6: e19415. PMID 21559295 DOI: 10.1371/Journal.Pone.0019415 |
0.441 |
|
2010 |
Santini E, Sgambato-Faure V, Li Q, Savasta M, Dovero S, Fisone G, Bezard E. Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. Plos One. 5: e12322. PMID 20808799 DOI: 10.1371/Journal.Pone.0012322 |
0.41 |
|
2010 |
Bateup HS, Santini E, Shen W, Birnbaum S, Valjent E, Surmeier DJ, Fisone G, Nestler EJ, Greengard P. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proceedings of the National Academy of Sciences of the United States of America. 107: 14845-50. PMID 20682746 DOI: 10.1073/Pnas.1009874107 |
0.46 |
|
2010 |
Santini E, Valjent E, Fisone G. mTORC1 signaling in Parkinson's disease and L-DOPA-induced dyskinesia: A sensitized matter. Cell Cycle (Georgetown, Tex.). 9: 2713-8. PMID 20581466 DOI: 10.4161/Cc.9.14.12323 |
0.482 |
|
2010 |
Napolitano F, Pasqualetti M, Usiello A, Santini E, Pacini G, Sciamanna G, Errico F, Tassone A, Di Dato V, Martella G, Cuomo D, Fisone G, Bernardi G, Mandolesi G, Mercuri NB, et al. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiology of Disease. 38: 434-45. PMID 20227500 DOI: 10.1016/J.Nbd.2010.03.003 |
0.428 |
|
2009 |
Valjent E, Bertran-Gonzalez J, Hervé D, Fisone G, Girault JA. Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. Trends in Neurosciences. 32: 538-47. PMID 19765834 DOI: 10.1016/J.Tins.2009.06.005 |
0.397 |
|
2009 |
Santini E, Heiman M, Greengard P, Valjent E, Fisone G. Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. Science Signaling. 2: ra36. PMID 19622833 DOI: 10.1126/Scisignal.2000308 |
0.47 |
|
2009 |
Santini E, Alcacer C, Cacciatore S, Heiman M, Hervé D, Greengard P, Girault JA, Valjent E, Fisone G. L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. Journal of Neurochemistry. 108: 621-33. PMID 19187092 DOI: 10.1111/J.1471-4159.2008.05831.X |
0.472 |
|
2009 |
Bertran-Gonzalez J, Håkansson K, Borgkvist A, Irinopoulou T, Brami-Cherrier K, Usiello A, Greengard P, Hervé D, Girault JA, Valjent E, Fisone G. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1710-20. PMID 19158668 DOI: 10.1038/Npp.2008.228 |
0.45 |
|
2009 |
Nordström E, Fisone G, Kristensson K. Opposing effects of ERK and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 613-22. PMID 18824519 DOI: 10.1096/Fj.08-115360 |
0.351 |
|
2008 |
Errico F, Rossi S, Napolitano F, Catuogno V, Topo E, Fisone G, D'Aniello A, Centonze D, Usiello A. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 10404-14. PMID 18842900 DOI: 10.1523/Jneurosci.1618-08.2008 |
0.319 |
|
2008 |
Westerlund M, Ran C, Borgkvist A, Sterky FH, Lindqvist E, Lundströmer K, Pernold K, Brené S, Kallunki P, Fisone G, Olson L, Galter D. Lrrk2 and alpha-synuclein are co-regulated in rodent striatum. Molecular and Cellular Neurosciences. 39: 586-91. PMID 18790059 DOI: 10.1016/J.Mcn.2008.08.001 |
0.372 |
|
2008 |
Korhonen L, Hansson I, Maugras C, Wehrle R, Kairisalo M, Borgkvist A, Jokitalo E, Sotelo C, Fisone G, Dusart I, Lindholm D. Expression of X-chromosome linked inhibitor of apoptosis protein in mature Purkinje cells and in retinal bipolar cells in transgenic mice induces neurodegeneration. Neuroscience. 156: 515-26. PMID 18765270 DOI: 10.1016/J.Neuroscience.2008.08.005 |
0.304 |
|
2008 |
Borgkvist A, Valjent E, Santini E, Hervé D, Girault JA, Fisone G. Delayed, context- and dopamine D1 receptor-dependent activation of ERK in morphine-sensitized mice. Neuropharmacology. 55: 230-7. PMID 18614186 DOI: 10.1016/J.Neuropharm.2008.05.028 |
0.412 |
|
2008 |
O'Sullivan GJ, Dunleavy M, Hakansson K, Clementi M, Kinsella A, Croke DT, Drago J, Fienberg AA, Greengard P, Sibley DR, Fisone G, Henshall DC, Waddington JL. Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling. Neuropharmacology. 54: 1051-61. PMID 18367215 DOI: 10.1016/J.Neuropharm.2008.02.011 |
0.336 |
|
2008 |
Santini E, Valjent E, Fisone G. Parkinson's disease: levodopa-induced dyskinesia and signal transduction. The Febs Journal. 275: 1392-9. PMID 18279379 DOI: 10.1111/J.1742-4658.2008.06296.X |
0.497 |
|
2008 |
Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology. 54: 815-23. PMID 18262573 DOI: 10.1016/J.Neuropharm.2007.12.011 |
0.353 |
|
2008 |
Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Molecular and Cellular Neurosciences. 37: 335-45. PMID 18035555 DOI: 10.1016/J.Mcn.2007.10.007 |
0.471 |
|
2008 |
Borgkvist A, Marcellino D, Fuxe K, Greengard P, Fisone G. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol. Neuropharmacology. 54: 31-5. PMID 17686497 DOI: 10.1016/J.Neuropharm.2007.06.025 |
0.484 |
|
2007 |
Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S. Adenosine A2A receptors and basal ganglia physiology. Progress in Neurobiology. 83: 277-92. PMID 17646043 DOI: 10.1016/J.Pneurobio.2007.05.001 |
0.411 |
|
2007 |
Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, Girault JA, Hervé D, Greengard P, Fisone G. Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6995-7005. PMID 17596448 DOI: 10.1523/Jneurosci.0852-07.2007 |
0.434 |
|
2007 |
Fisone G, Håkansson K, Borgkvist A, Santini E. Signaling in the basal ganglia: postsynaptic and presynaptic mechanisms. Physiology & Behavior. 92: 8-14. PMID 17585965 DOI: 10.1016/J.Physbeh.2007.05.028 |
0.468 |
|
2007 |
Borgkvist A, Usiello A, Greengard P, Fisone G. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1995-2003. PMID 17251906 DOI: 10.1038/Sj.Npp.1301321 |
0.42 |
|
2007 |
Borgkvist A, Fisone G. Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neuroscience and Biobehavioral Reviews. 31: 79-88. PMID 16730373 DOI: 10.1016/J.Neubiorev.2006.03.003 |
0.447 |
|
2006 |
Håkansson K, Galdi S, Hendrick J, Snyder G, Greengard P, Fisone G. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. Journal of Neurochemistry. 96: 482-8. PMID 16336634 DOI: 10.1111/J.1471-4159.2005.03558.X |
0.468 |
|
2006 |
Borgkvist A, Puelles E, Carta M, Acampora D, Ang SL, Wurst W, Goiny M, Fisone G, Simeone A, Usiello A. Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Molecular and Cellular Neurosciences. 31: 293-302. PMID 16256364 DOI: 10.1016/J.Mcn.2005.09.018 |
0.45 |
|
2005 |
Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, Svenningsson P, Fredholm BB, Borrelli E, Greengard P, Fisone G. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8432-8. PMID 16162925 DOI: 10.1523/Jneurosci.1289-05.2005 |
0.757 |
|
2005 |
Lundblad M, Usiello A, Carta M, HÃ¥kansson K, Fisone G, Cenci MA. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Experimental Neurology. 194: 66-75. PMID 15899244 DOI: 10.1016/J.Expneurol.2005.02.002 |
0.392 |
|
2005 |
Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, HÃ¥kansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, et al. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism & Related Disorders. 11: S25-9. PMID 15885624 DOI: 10.1016/J.Parkreldis.2004.11.005 |
0.428 |
|
2005 |
Aubert I, Guigoni C, HÃ¥kansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Annals of Neurology. 57: 17-26. PMID 15514976 DOI: 10.1002/Ana.20296 |
0.43 |
|
2004 |
Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology. 47: 14-23. PMID 15464122 DOI: 10.1016/J.Neuropharm.2004.05.010 |
0.385 |
|
2004 |
Håkansson K, Pozzi L, Usiello A, Haycock J, Borrelli E, Fisone G. Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol European Journal of Neuroscience. 20: 1108-1112. PMID 15305880 DOI: 10.1111/J.1460-9568.2004.03547.X |
0.745 |
|
2004 |
Håkansson K, Lindskog M, Pozzi L, Usiello A, Fisone G. DARPP-32 and modulation of cAMP signaling: Involvement in motor control and levodopa-induced dyskinesia Parkinsonism and Related Disorders. 10: 281-286. PMID 15196506 DOI: 10.1016/J.Parkreldis.2004.02.010 |
0.752 |
|
2004 |
Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences : Cmls. 61: 857-72. PMID 15095008 DOI: 10.1007/S00018-003-3269-3 |
0.442 |
|
2004 |
Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission. Annual Review of Pharmacology and Toxicology. 44: 269-96. PMID 14744247 DOI: 10.1146/Annurev.Pharmtox.44.101802.121415 |
0.423 |
|
2003 |
Collin M, Bäckberg M, Ovesjö ML, Fisone G, Edwards RH, Fujiyama F, Meister B. Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. The European Journal of Neuroscience. 18: 1265-78. PMID 12956725 DOI: 10.1046/J.1460-9568.2003.02840.X |
0.322 |
|
2003 |
Pozzi L, HÃ¥kansson K, Usiello A, Borgkvist A, Lindskog M, Greengard P, Fisone G. Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. Journal of Neurochemistry. 86: 451-9. PMID 12871586 DOI: 10.1046/J.1471-4159.2003.01851.X |
0.721 |
|
2003 |
Picconi B, Centonze D, HÃ¥kansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nature Neuroscience. 6: 501-6. PMID 12665799 DOI: 10.1038/Nn1040 |
0.387 |
|
2003 |
Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P, Hokfelt T, Borrelli E, Fisone G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proceedings of the National Academy of Sciences of the United States of America. 100: 4305-9. PMID 12651945 DOI: 10.1073/Pnas.0730708100 |
0.421 |
|
2002 |
Hökfelt T, Blacker D, Broberger C, Herrera-Marschitz M, Snyder G, Fisone G, Cortés R, Morino P, You ZB, Ogren SO. Some aspects on the anatomy and function of central cholecystokinin systems. Pharmacology & Toxicology. 91: 382-6. PMID 12688383 DOI: 10.1034/J.1600-0773.2002.910617.X |
0.659 |
|
2002 |
Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, Fisone G. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature. 418: 774-8. PMID 12181566 DOI: 10.1038/Nature00817 |
0.721 |
|
2002 |
Lindgren N, Goiny M, Herrera-Marschitz M, Haycock JW, Hökfelt T, Fisone G. Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. The European Journal of Neuroscience. 15: 769-73. PMID 11886455 DOI: 10.1046/J.1460-9568.2002.01901.X |
0.44 |
|
2001 |
Lindgren N, Xu ZQ, Herrera-Marschitz M, Haycock J, Hökfelt T, Fisone G. Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. The European Journal of Neuroscience. 13: 773-80. PMID 11207812 DOI: 10.1046/J.0953-816X.2000.01443.X |
0.466 |
|
2000 |
Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, Greengard P, Fredholm BB. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. Journal of Neurochemistry. 75: 248-57. PMID 10854268 DOI: 10.1046/J.1471-4159.2000.0750248.X |
0.43 |
|
2000 |
Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proceedings of the National Academy of Sciences of the United States of America. 97: 1856-60. PMID 10677546 DOI: 10.1073/Pnas.97.4.1856 |
0.442 |
|
1999 |
Nishi A, Fisone G, Snyder GL, Dulubova I, Aperia A, Nairn AC, Greengard P. Regulation of Na+, K+-ATPase isoforms in rat neostriatum by dopamine and protein kinase C. Journal of Neurochemistry. 73: 1492-501. PMID 10501194 DOI: 10.1046/J.1471-4159.1999.0731492.X |
0.379 |
|
1999 |
Nishi A, Snyder GL, Fienberg AA, Fisone G, Aperia A, Nairn AC, Greengard P. Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation. The European Journal of Neuroscience. 11: 2589-92. PMID 10383649 DOI: 10.1046/J.1460-9568.1999.00724.X |
0.424 |
|
1999 |
Lindskog M, Svenningsson P, Fredholm B, Greengard P, Fisone G. Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons. The European Journal of Neuroscience. 11: 2182-6. PMID 10336688 DOI: 10.1046/J.1460-9568.1999.00597.X |
0.424 |
|
1999 |
Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience. 88: 1005-8. PMID 10336115 DOI: 10.1016/S0306-4522(98)00411-4 |
0.444 |
|
1998 |
Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience. 84: 223-8. PMID 9522376 DOI: 10.1016/S0306-4522(97)00510-1 |
0.48 |
|
1998 |
Fisone G, Snyder GL, Aperia A, Greengard P. Na+,K+-ATPase Phosphorylation in the Choroid Plexus: Synergistic Regulation by Serotonin/Protein Kinase C and Isoproterenol/cAMP-PK/PP-1 Pathways Molecular Medicine. 4: 258-265. DOI: 10.1007/Bf03401922 |
0.326 |
|
1995 |
Fisone G, Snyder GL, Fryckstedt J, Caplan MJ, Aperia A, Greengard P. Na+,K(+)-ATPase in the choroid plexus. Regulation by serotonin/protein kinase C pathway. The Journal of Biological Chemistry. 270: 2427-30. PMID 7852300 DOI: 10.1074/Jbc.270.6.2427 |
0.312 |
|
1994 |
Snyder GL, Fisone G, Greengard P. Phosphorylation of DARPP-32 is regulated by GABA in rat striatum and substantia nigra Journal of Neurochemistry. 63: 1766-1771. PMID 7931332 DOI: 10.1046/J.1471-4159.1994.63051766.X |
0.371 |
|
1993 |
Snyder GL, Fisone G, Morino P, Gundersen V, Ottersen OP, Hökfelt T, Greengard P. Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. Proceedings of the National Academy of Sciences of the United States of America. 90: 11277-81. PMID 8248241 DOI: 10.1073/Pnas.90.23.11277 |
0.449 |
|
1992 |
Fisone G, Bartfai T, Nilsson S, Hökfelt T. Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Research. 568: 279-84. PMID 1726068 DOI: 10.1016/0006-8993(91)91409-T |
0.334 |
|
1992 |
Amoroso D, Girotti P, Fisone G, Bartfai T, Consolo S. Mechanism of the galanin induced increase in acetylcholine release in vivo from striata of freely moving rats Brain Research. 589: 33-38. PMID 1384927 DOI: 10.1016/0006-8993(92)91158-B |
0.346 |
|
1992 |
Bartfai T, Fisone G, Langel U. Galanin and galanin antagonists: molecular and biochemical perspectives. Trends in Pharmacological Sciences. 13: 312-7. PMID 1384214 DOI: 10.1016/0165-6147(92)90098-Q |
0.344 |
|
1991 |
Palazzi E, Felinska S, Zambelli M, Fisone G, Bartfai T, Consolo S. Galanin reduces carbachol stimulation of phosphoinositide turnover in rat ventral hippocampus by lowering Ca2+ influx through voltage-sensitive Ca2+ channels. Journal of Neurochemistry. 56: 739-47. PMID 1704418 DOI: 10.1111/J.1471-4159.1991.Tb01986.X |
0.325 |
|
1990 |
Fisone G, Berthold M, Bedecs K, Undén A, Bartfai T, Bertorelli R, Consolo S, Crawley J, Martin B, Nilsson S. N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proceedings of the National Academy of Sciences of the United States of America. 86: 9588-91. PMID 2594786 DOI: 10.1073/Pnas.86.23.9588 |
0.325 |
|
1990 |
Consolo S, Palazzi E, Bertorelli R, Fisone G, Crawley J, Hokfelt T, Bartfai T. Functional aspects of acetylcholine-galanin coexistence in the brain. Progress in Brain Research. 84: 279-287. PMID 1702545 DOI: 10.1016/S0079-6123(08)60912-7 |
0.338 |
|
1990 |
Crawley J, Austin M, Fiske S, Martin B, Consolo S, Berthold M, Langel U, Fisone G, Bartfai T. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus The Journal of Neuroscience. 10: 3695-3700. DOI: 10.1523/Jneurosci.10-11-03695.1990 |
0.301 |
|
1989 |
Melander T, Bartfai T, Brynne N, Consolo S, Fisone G, Hokfelt T, Kohler C, Nordstrom O, Norheim-Theodorsson E, Persson A, Sedvall G, Staines WA, Wu CF. Galanin in the cholinergic basal forebrain: histochemical, autoradiographic and in vivo studies Progress in Brain Research. 79: 85-91. PMID 2479959 DOI: 10.1016/S0079-6123(08)62467-X |
0.333 |
|
1988 |
Tacconi MT, Fisone G, Consolo S. Modulation of phospholipid methylation in rat striatum by the corticostriatal pathway. Brain Research. 461: 194-8. PMID 3066434 DOI: 10.1016/0006-8993(88)90741-X |
0.347 |
|
1987 |
Fisone G, Wu CF, Consolo S, Nordstrom O, Brynne N, Bartfai T, Melander T, Hokfelt T. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies Proceedings of the National Academy of Sciences of the United States of America. 84: 7339-7343. PMID 2444980 DOI: 10.1073/Pnas.84.20.7339 |
0.314 |
|
1986 |
Forloni G, Fisone G, Consolo S, Ladinsky H. Qualitative differences in the effects of adenosine analogs on the cholinergic systems of rat striatum and hippocampus Naunyn-Schmiedebergs Archives of Pharmacology. 334: 86-91. PMID 3024027 DOI: 10.1007/Bf00498744 |
0.398 |
|
Show low-probability matches. |